Please login to the form below

Not currently logged in
Email:
Password:

brain

This page shows the latest brain news and features for those working in and with pharma, biotech and healthcare.

New data backs GeNeuro’s MS drug after Servier exit

New data backs GeNeuro’s MS drug after Servier exit

in brain atrophy, during this 96-week extension phase. ... stage of the disease and represent irreversible damage to the brain.

Latest news

More from news
Approximately 3 fully matching, plus 563 partially matching documents found.

Latest Intelligence

  • Detecting Alzheimer’s ahead of a cure Detecting Alzheimer’s ahead of a cure

    Not only can it predict Alzheimer’s early, but the blood test is possibly more effective than the current standard of detection, a PET brain scan, according to the researchers. ... According to the charity, AstronauTx was formed to develop new

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    plaques and oligomers formed by beta-amyloid occur outside the brain cells of people with Alzheimer’s. ... It has long been known that brain immune cells called microglia maintain a healthy brain environment by clearing debris, including misfolded

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    Elsewhere, J&J is working with the University of Pennsylvania on gene therapies capable of triggering the production of antibodies in the brain. ... Read more: Brain power: fresh approaches to Alzheimer's drug discovery.

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Alector has devoted the last five years to the development of novel therapeutics that harness the brain’s immune system to treat neurodegeneration, identifying over 40 immune system targets, progressing more ... of a protein called TDP-43 that builds

  • Rare Diseases Day Rare Diseases Day

    They are focusing on enabling access to data and patients to drive the creation of an evidence base, while also helping firms to access the best brains needed to create a

More from intelligence
Approximately 0 fully matching, plus 50 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 76 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics